CAR-T Cancer Approach Has Surprising Success in Multiple Myeloma
Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that's on the rise. Although it's early and the study is small -- 35 people -- every patient responded and all but two were in some level of remission within two months. In a second study of nearly two dozen…